Abstract
Objective:
To explore the association of promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene with obesity.
Subjects:
In total, 213 nondiabetic Japanese subjects. They were divided into three groups according to World Health Organization definitions: lean (body mass index (BMI) <25 kg/m2), overweight (25⩽BMI<30 kg/m2) and obese (BMI⩾30 kg/m2).
Methods:
We examined two polymorphic loci in the MIF gene in the subjects: a single-nucleotide polymorphism at position −173 (G/C) and a CATT-tetranucleotide repeat polymorphism at position −794, which both can affect promoter activity in different cells.
Results:
We detected four alleles: 5-, 6-, 7- and 8-CATT at position −794. Genotypes without the 5-CATT allele (X/X, X refers to 6-, 7- or 8-CATT alleles) were more common in obese subjects than in lean or overweight groups (P=0.013). The X-CATT allele was more frequent in obese subjects than in lean or overweight subjects (P=0.030). In contrast, −173G/C was not associated with obesity. Among the haplotypes of the two promoter polymorphisms, G/5-CATT ((−173G/C)/(−794[CATT]5–8)) was associated with a decreased risk of obesity (P=0.025) and G/6-CATT with an increased risk of overweight (P=0.028).
Conclusion:
Promoter polymorphism in the MIF gene is linked with obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maes HH, Neale MC, Eaves LJ . Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997; 27: 325–351.
Bernhagen J, Calandra T, Bucala R . Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med 1998; 76: 151–161.
Trayhurn P, Wood IS . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347–355.
Nishihira J . Novel pathophysiological aspects of macrophage migration inhibitory factor. Int J Mol Med 1998; 2: 17–28.
Waeber G, Calandra T, Roduit R, Haefliger JA, Bonny C, Thompson N et al. Insulin secretion is regulated by the glucose-dependent production of islet β cell macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1997; 94: 4782–4787.
Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, Peng T et al. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 2000; 106: 1291–1300.
Hirokawa J, Sakaue S, Furuya Y, Ishii J, Hasegawa A, Tagami S et al. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-α. Biochem Biophys Res Commun 1997; 235: 94–98.
Sakaue S, Nishihira J, Hirokawa J, Yoshimura H, Honda T, Aoki K et al. Regulation of macrophage migration inhibitory factor (MIF) expression by glucose and insulin in adipocytes in vitro. Mol Med 1999; 5: 361–371.
Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004; 89: 5043–5047.
Rice T, Chagnon YC, Pérusse L, Borecki IB, Ukkola O, Rankinen T et al. A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes 2002; 51: 848–855.
Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170–176.
Donn RP, Shelley E, Ollier WE, Thomson W, British Paediatric Rheumatology Study Group. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782–1785.
Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M . Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 2004; 169: 1014–1018.
Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 2004; 123: 484–487.
Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, et al., British Paediatric Rheumatology Study Group. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402–2409.
Terwillinger JD, Ott J . Handbook of Human Genetic Linkage. Johns Hopkins University Press: Baltimore, 1994.
Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA . Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425–434.
Examination Committee of Criteria for ‘Obesity Disease’ in Japan. Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J 2002; 66: 987–992.
Hotamisligil GS, Shargill NS, Spiegelman BM . Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM . Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–2415.
Hotamisligil GS . The role of TNFα and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245: 621–625.
Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ . Journey from cachexia to obesity by TNF. FASEB J 1997; 11: 743–751.
Warne JP . Tumour necrosis factor α: a key regulator of adipose tissue mass. J Endocrinol 2003; 177: 351–355.
Norman RA, Bogardus C, Ravussin E . Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. J Clin Invest 1995; 96: 158–162.
Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J et al. The TNF-α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468–1472.
Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A et al. Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28: 59–66.
Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P et al. Role of tumor necrosis factor-α gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension 2000; 36: 14–19.
Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P . Excessive fat accumulation is associated with the TNF α –308 G/A promoter polymorphism in women but not in men. Diabetologia. 2000; 43: 117–120.
Kamizono S, Yamada K, Seki N, Higuchi T, Kimura A, Nonaka K et al. Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region of the tumor necrosis factor-α gene. Tissue Antigens 2000; 55: 449–452.
Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, Distler A et al. Tumor necrosis factor-α–308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 2001; 25: 581–585.
Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID . Association of the TNF-α –308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 2002; 10: 401–407.
Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–1830.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.
Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R . Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994; 33: 14144–14155.
Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H . Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 2005; 146: 1006–1011.
Donn R, Alourfi Z, Zeggini E, Lamb R, Jury F, Lunt M, et al., British Paediatric Rheumatology Study Group. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50: 1604–1610.
Shimizu T, Hizawa N, Honda A, Zhao Y, Abe R, Watanabe H et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun 2005; 6: 285–289.
Acknowledgements
We would like to thank all participants in this study. We also thank the nursing staff of Kohnan hospital for blood sampling and Y Obata for valuable technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sakaue, S., Ishimaru, S., Hizawa, N. et al. Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity. Int J Obes 30, 238–242 (2006). https://doi.org/10.1038/sj.ijo.0803148
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0803148
Keywords
This article is cited by
-
The macrophage migration inhibitory factor protein superfamily in obesity and wound repair
Experimental & Molecular Medicine (2015)
-
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
International Journal of Obesity (2009)
-
The role of macrophage migration inhibitory factor on glucose metabolism and diabetes
Diabetologia (2008)
-
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002
Diabetologia (2008)